Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
about
Treatment of prediabetesExercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance.Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism.Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.Effects of exercise intensity on postprandial improvement in glucose disposal and insulin sensitivity in prediabetic adults.Plasma glucose concentration and prediction of future risk of type 2 diabetes.Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose.Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.Prediabetes Phenotype Influences Improvements in Glucose Homeostasis with Resistance TrainingNormal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults.Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study.Plasma C1q/TNF-Related Protein-3 (CTRP-3) and High-Mobility Group Box-1 (HMGB-1) Concentrations in Subjects with Prediabetes and Type 2 Diabetes.Pancreatic β-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes.The potential role of glutamate in the current diabetes epidemic.What are the pharmacotherapy options for treating prediabetes?Baseline level of 30-min plasma glucose is an independent predictor of incident diabetes among Asian Indians: analysis of two diabetes prevention programmes.Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.Molecular mechanisms of muscarinic acetylcholine receptor-stimulated increase in cytosolic free Ca(2+) concentration and ERK1/2 activation in the MIN6 pancreatic β-cell line.Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.1-Hour plasma glucose in obese youth.The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study.β-Cell function in postmenopausal women with isolated post-challenge hyperglycemia.Comparison of β-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia.Index of glucose effectiveness derived from oral glucose tolerance test.The Vasculature in Prediabetes.Ultrastructural morphometric analysis of insulin secretory granules in human type 2 diabetesPPARG2 Pro12Ala and ADAMTS9 rs4607103 as “insulin resistance loci” and “insulin secretion loci” in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4
P2860
Q26783350-0695DA37-8A53-4C5A-9789-CC432B76AC78Q30276917-5792A172-0EAA-4373-AE5F-0DFD2BA15374Q30276925-54E84BC8-22ED-4867-A374-16B438CEE25AQ30359255-B7F9551F-4A0D-4C42-9AF3-0D33118B6834Q30408824-8CED359F-EA5F-4763-A179-BC74D2F281D9Q33610774-8FB920CF-833D-4BDA-96C8-B17FC0674A54Q33683685-A6CC372D-22CA-40E2-81E3-4D9A59D0DE04Q34131002-457C7D30-D1A2-42E1-9BB6-1E48EB8189EEQ35913470-4240322D-E468-4A43-A4AA-508607B8F041Q35986465-F099230A-210B-44DD-A3EB-AE692366E147Q36124167-3E7B054C-929A-414C-995C-91A6F6069079Q37206056-0442F32A-74B3-4A77-A253-DA806AB9EB0FQ37322676-9F1A4A69-F758-4BCE-8D45-A3E6C647796FQ37341968-8C10BEDD-792A-4CF4-AB5C-C06888ABA112Q37973276-1B3D172E-B3EB-4F55-9E74-A2B1DC10EAFDQ38241464-95B2B84C-C3EF-452F-AEB9-F6AB674658FCQ38893233-BD4FB0A7-BB12-4C0A-921A-9E5FF8C64A6CQ39298394-9A9BB2E4-E37D-43B3-BF83-71C4F1E646CEQ39491872-3FA13B7E-6585-4CE1-9B26-AADD6ACD0274Q41759595-0D10F3FC-EDE9-41FF-85C2-3F28F9669A81Q44411397-37940B40-FD6B-4B5E-ADD9-47A06A9BF43AQ44597770-37468D03-7AD0-499A-8AF2-D86DFED25ECCQ47876102-5669B433-60C5-4DBC-A11E-D45326BCB4E8Q48221716-B5A63C76-CBA3-42BE-B195-0490429FBF4BQ51339801-8E9ACDF1-EB9C-4C62-8001-B8F59549C116Q53695913-7DCA65ED-34A1-45C1-91F9-9C25913AF3AFQ57503376-B592369B-8440-44F1-9E86-E41A83097447Q58885867-E3B3D4CA-72DA-4C76-B020-881C4B4D3D9B
P2860
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impaired early- but not late-p ...... with impaired fasting glucose.
@en
Impaired early- but not late-p ...... with impaired fasting glucose.
@nl
type
label
Impaired early- but not late-p ...... with impaired fasting glucose.
@en
Impaired early- but not late-p ...... with impaired fasting glucose.
@nl
prefLabel
Impaired early- but not late-p ...... with impaired fasting glucose.
@en
Impaired early- but not late-p ...... with impaired fasting glucose.
@nl
P2093
P2860
P1433
P1476
Impaired early- but not late-p ...... with impaired fasting glucose.
@en
P2093
Chris Jenkinson
Diedre Winnier
Muhammad A Abdul-Ghani
Mustafa Kanat
P2860
P2888
P304
P356
10.1007/S00592-011-0285-X
P577
2011-05-08T00:00:00Z